Market Access/ News/ News AbbVie’s Orilissa gets FDA nod as Humira competition looms Richard Staines AbbVie, Biogen, endometriosis 0 Comment AbbVie needs new drugs as its mega-blockbuster Humira won’t bring in billions forever – and after the embarrassing Share X AbbVie’s Orilissa gets FDA nod as Humira competition looms https://pharmaphorum.com/news/abbvies-orlissa-gets-fda-nod-as-humira-competition-looms/
News/ R&D Forendo joins race to develop endometriosis drugs Richard Staines endometriosis, Forendo Pharma, Takeda 0 Comment Finland’s Forendo Pharma is beginning early-stage trials of a potential new treatment for endometriosis, joining a gang of Share X Forendo joins race to develop endometriosis drugs https://pharmaphorum.com/news/forendo-joins-race-to-develop-endometriosis-drugs/
News AbbVie’s elagolix shows promise in uterine fibroids treatment Andrew McConaghie AbbVie, elagolix, endometriosis, Neurocrine Biosciences, uterine fibroids 0 Comment AbbVie’s elagolix has shown promise in a phase 2 trial in women with uterine fibroids, a second indication for Share X AbbVie’s elagolix shows promise in uterine fibroids treatment https://pharmaphorum.com/news/abbvies-elagloix-shows-promise-uterine-fibroids-treatment/
